ArticleJournal of inflammation research2025
The Correlation Study of Bone Metabolism and Inflammatory Markers with Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea Syndrome.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea syndrome (OSAS) elevates the risk of major adverse cardiovascular events (MACEs), though the underlying mechanisms are not fully elucidated. This study investigated the correlations between bone metabolism markers, inflammatory cytokines, and MACEs in OSAS patients. Methods: A retrospective study was conducted on patients diagnosed with OSAS between March 2019 and March 2022, alongside baseline characteristics - matched controls without OSAS. The cohort comprised 496 OSAS patients and 545 controls. Based on the occurrence of major adverse cardiovascular events (MACEs), the entire cohort (n=1041) was segregated into a MACE group (n=120) and a non-MACE group (n=921). Clinical data collected included demographic information, polysomnography results, bone metabolism markers (β-CrossLaps [β-CTX], total procollagen type I N-terminal propeptide [TPINP]), and inflammatory cytokines (interleukin-1 beta [IL-1β], interleukin-6 [IL-6], C-reactive protein [CRP], tumor necrosis factor-alpha [TNF-α], interleukin-10 [IL-10], interferon-gamma [IFN-γ]). Statistical analyses included independent t tests, Pearson correlation coefficients, logistic regression, and structural equation modeling. Results: OSAS patients showed significantly higher β-CTX (0.49±0.15 vs 0.43±0.14 ng/mL; P<0.001) and lower TPINP (103.81±37.57 vs 118.19±41.20 ng/mL; P<0.001) than controls. Levels of IL-6, TNF-α, and IL-1β were also elevated in the OSAS group (all P<0.01). MACEs were more frequent in OSAS patients (P=0.002). Multivariate analysis identified severe OSAS (OR=2.771, P<0.001), elevated IL-6 (OR=1.114, P=0.013), elevated IL-1β (OR=1.598, P=0.033), and increased β-CTX (OR=3.386, P<0.001) as independent MACE predictors. SEM revealed OSAS directly associated with MACEs (β=0.18) and indirectly via inflammatory and bone metabolism pathways. Conclusion: Altered bone metabolism markers and elevated pro-inflammatory cytokines are associated with an increased risk of MACEs in OSAS patients, suggesting their role in the pathophysiology of OSAS-related cardiovascular morbidity. Monitoring these markers could aid in risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.